SERUM LEVELS OF L-FABP AND CATHELICIDIN AS DIAGNOSTIC MARKERS FOR KIDNEY PATHOLOGIES IN DIABETIC PATIENTS

Authors

  • N.F. Latifova Azerbaijan Medical University
  • I.J. Shahverdieva Azerbaijan Medical University
  • G.R. Vahabova Azerbaijan Medical University
  • S.R. Guliyeva Azerbaijan Medical University
  • D.M. Aliyeva Azerbaijan Medical University

DOI:

https://doi.org/10.34921/amj.2023.3.011

Keywords:

diabetes, diabetic glomerulopathy, L-FABP (liver fatty acid binding protein), cathelicidin, chronic renal failure

Abstract

The article presents information on the diagnostic value of L-FABP (liver fatty acid binding protein) and cathelicidin proteins in blood serum in chronic renal failure complicated by diabetes mellitus. The study included data on cathelicidin and L-FABP in the blood serum of 84 patients with type II diabetes mellitus and 17 healthy individuals (control group). Patients with diabetes mellitus were divided into 3 groups: uncomplicated glomerulopathy (n=28), glomerulopathy (n=28) and complicated by chronic renal failure (n=28). The level of cathelicidin in the blood serum did not differ statistically in the studied groups, and a statistically significant increase in the level of L-FABP was observed in all three diabetic groups compared with the control.

Downloads

Download data is not yet available.

Published

2023-09-30

How to Cite

Latifova, N., Shahverdieva, I., Vahabova, G., Guliyeva, S., & Aliyeva, D. (2023). SERUM LEVELS OF L-FABP AND CATHELICIDIN AS DIAGNOSTIC MARKERS FOR KIDNEY PATHOLOGIES IN DIABETIC PATIENTS. Azerbaijan Medical Journal, (3), 71–74. https://doi.org/10.34921/amj.2023.3.011

Issue

Section

CLINICAL RESEARCH